Scholars Central

Review articlePublished 11 Aug 2021

Diagnostic and Prognostic Biomarkers of Heart Failure: The Impacts, Implementation and Future Outcomes

Authors: Ahmed Bader

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Heart failure (HF) is a major leading cause of mortality and morbidity worldwide. The primary and secondary preventions of chronic heart failure are a priority for the health system and require multiple approaches to increase their effectiveness. Serum Cardiac Biomarkers are tools used to more accurately identify high-risk individuals of chronic Heart Failure, to speed the diagnosis, and to aid in treatment and prognosis determination. This review aims to highlight the importance of utilization of a variety of these cardiac biomarkers in assessment of asymptomatic HF patients, and decompensated symptomatic cases of chronic heart failure and to raise relevant points of their clinical use and the promises for the coming years for better management under different types of pharmacotherapeutic lines for treatment of chronic heart failure.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews: Journal of Hospital and Clinical Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews: Journal of Hospital and Clinical Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ahmed Bader”